Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on February 13, 2025, reports on Cellebrite DI Ltd.'s Fourth-Quarter and Full-Year 2024 results. The filing serves as a conduit for a press release furnished as Exhibit 99.1, which contains the detailed financial performance data.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and are incorporated by reference into the company's registration statements on Form S-8 and Form F-3.
Material Changes
The filing text does not disclose specific material changes versus prior periods. Comparative analysis of the fourth quarter and full-year 2024 results against prior periods is detailed in the referenced press release.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are not explicitly stated in the Form 6-K cover text. Investors must refer to the attached press release for the company's outlook and discussion of unusual items.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and Full-Year 2024 revenue and net income figures.
- Verify year-over-year growth rates and margin trends in the attached financial tables.
- Examine the press release for updated full-year 2025 guidance and management commentary on market conditions.
- Confirm the incorporation of GAAP financial statements into the referenced Form S-8 and Form F-3 registration statements.